Peter Strothman has spent his career investing in the healthcare and private equity industries. He specializes in life sciences, specialty pharmaceutical products and services, and general healthcare products and services. Peter has built a leading group of pharmaceutical companies for Water Street and established an innovative corporate partnership program that supports the world’s leading healthcare companies with leveraging their investment in developing pharmaceutical and medical device products. Prior to Water Street, Peter was a principal with JLL Partners, where he focused exclusively on healthcare investments. He began his career in the Global Mergers and Acquisitions group of Lehman Brothers. Peter currently serves as a director of Allucent, CXV Global & Panacea Technologies, EVERSANA, Discovery Life Sciences, Capstone Development Solutions, Long Grove Pharmaceuticals, Solvias, THREAD and Viant. He is a former director of AAIPharma Services, Bioclinica, Custopharm, and OraPharma. Peter received a bachelor’s degree in economics from Harvard University.